SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-045309
Filing Date
2021-11-18
Accepted
2021-11-18 19:00:23
Documents
1
Period of Report
2021-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3584
  Complete submission text file 0000899243-21-045309.txt   5029
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address C/O COMPASS 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address
Bisker-Leib Vered (Reporting) CIK: 0001814093 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39696 | Film No.: 211425983